ALNY one of the best balance sheets out there. Nearly $6 a share net cash ($270m net) with about $14m a qtr burn - assuming same burn rate they have nearly 6 years of cash. I think they would be makign a mistake by significantly ramping up expenses by goign forward to more expensive trials without someone sharing some/most of the cost burden.